PTK2 and neoplasm: For instance, caspase-3 activation in ovarian cancer following VP-16 treatment can paradoxically drive tumor repopulation through iPLA2–PGE2–FAK signaling, whereas in combination with proteasome inhibitors it induces robust apoptosis [100, 101].